目前的RNA策略用于治疗心血管疾病
Shirley Pei Shan Chia1, Jeremy Kah Sheng Pang2, Boon-Seng Soh1
1Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore; Department of Biological Sciences, National University of Singapore, 16 Science Drive 4, Singapore 117558, Singapore.
通过向特定的基因,RNA疗法提供了一种治疗心血管疾病 (CVD) 的新方法. 本综述探讨了基因和获得性心血管疾病的基于RNA的策略,强调了传递挑战和未来的潜力.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 在RNA治疗方面,RNA疗法.
背景情况:
- 心血管疾病 (CVD) 仍然是全球主要的健康挑战.
- 目前的治疗方法往往不足以解决复杂的分子机制.
- 迫切需要创新的治疗策略.
研究的目的:
- 审查目前的RNA治疗心血管疾病 (CVD) 的现状.
- 为了确定门德尔和获得心血管疾病的共同基因标.
- 讨论RNA治疗性向心血管系统传递的挑战和机遇.
主要方法:
- 基于RNA的治疗方式的综合文献综述.
- 对相关的基因标分析心血管疾病的发病.
- 对心血管应用的RNA输送策略的评估.
主要成果:
- 通过针对核心教条,RNA疗法提供了暂时或永久的修改.
- 确定了门德尔和获得心血管疾病的共同基因标.
- 交付策略为心血管向提供了关键的挑战和机会.
结论:
- 基于RNA的干预措施代表了对抗心血管疾病的新而精确的方法.
- 向基因疗法对未来的心血管治疗具有重大潜力.
- 对传递机制的进一步研究对于临床转化至关重要.
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...


